Both in Biotechnology
Anavex Life Sciences vs Protalix BioTherapeutics
Over the past year AVXL returned −72.7% and PLX returned +24.5%; their daily moves had a correlation of 0.12.
AVXL −72.7% PLX +24.5%Growth of $1, one year, split-adjusted
| Metric | AVXL | PLX |
|---|---|---|
| Price | $2.36 | $2.69 |
| Market cap | $218.8M | $216.7M |
| Today | +0.43% | 0.00% |
| 1 month | −21.1% | +5.9% |
| 6 months | −16.3% | +28.7% |
| Year to date | −33.7% | +49.4% |
| 1 year | −72.7% | +30.6% |
| Revenue growth (YoY) | — | +27.1% |
| Gross margin | — | 61.0% |
| Net margin | — | 19.0% |
| P/E (TTM) | — | 11.4× |
| Price / sales | — | 2.7× |
| Net cash | $118.3M | $40.7M |
| Dividend yield | — | — |
| Volatility (60d) | 67.0% | 43.8% |
| Short % of float | 16.0% | 3.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).